HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 3.210
-0.110 (-3.31%)
May 28, 2026, 3:59 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.9 billion as of May 28, 2026. Its market cap has increased by 41.72% in one year.
Market Cap
1.90B
Enterprise Value
1.54B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.21
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.90B, a decrease of -70.24%. That is a compound annual growth rate of -39.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.83B | 8.81% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Antengene Corporation | 2.99B |
| Viva Biotech Holdings | 2.92B |
| AIM Vaccine | 2.89B |
| SinoMab BioScience | 1.82B |
| Mabpharm | 1.75B |
| Frontage Holdings | 1.66B |
| Beijing Biostar Pharmaceuticals | 1.53B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.49B |